{"id":"https://openalex.org/W2008122290","doi":"https://doi.org/10.1517/13543784.12.4.655","title":"Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic","display_name":"Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2008122290","doi":"https://doi.org/10.1517/13543784.12.4.655","mag":"2008122290","pmid":"https://pubmed.ncbi.nlm.nih.gov/12665420"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.12.4.655","doi":"https://doi.org/10.1517/13543784.12.4.655","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.12.4.655","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2008122290"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111982959","display_name":"P E Keck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143084","display_name":"Cincinnati VA Medical Center","ror":"https://ror.org/045r80n66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210127612","https://openalex.org/I4210143084"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul E Keck Jr","raw_affiliation_strings":["Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine and General Clinical Research Center, Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine and General Clinical Research Center, Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA","institution_ids":["https://openalex.org/I4210143084","https://openalex.org/I63135867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079329164","display_name":"Susan L. McElroy","orcid":"https://orcid.org/0000-0002-8879-0865","observed_orcids":["https://orcid.org/0000-0002-8879-0865"]},"institutions":[{"id":"https://openalex.org/I4210143084","display_name":"Cincinnati VA Medical Center","ror":"https://ror.org/045r80n66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210127612","https://openalex.org/I4210143084"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan L McElroy","raw_affiliation_strings":["Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine and General Clinical Research Center, Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine and General Clinical Research Center, Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA","institution_ids":["https://openalex.org/I4210143084","https://openalex.org/I63135867"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0395,"has_fulltext":false,"cited_by_count":124,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.68490879,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"12","issue":"4","first_page":"655","last_page":"662"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":1.0},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-partial-agonist","display_name":"dopamine D2 receptor partial agonist","score":0.8140000104904175},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.968999981880188},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.6949999928474426},{"id":"https://openalex.org/keywords/positive-and-negative-symptoms","display_name":"positive and negative symptoms","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mood-symptoms","display_name":"mood symptoms","score":0.8500000238418579},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.9169999957084656},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8180000185966492},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9800000190734863},{"id":"https://openalex.org/keywords/neurological-adverse-events","display_name":"neurological adverse events","score":0.7860000133514404},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.7429999709129333},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9676722884178162},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.9185799360275269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5478881597518921},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5291281938552856},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5166857242584229},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.49936509132385254},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.48079338669776917},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.471100389957428},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4521976113319397},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4215160012245178},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.38557007908821106},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.34684133529663086},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3384366035461426},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.311190128326416},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12085524201393127}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/13543784.12.4.655","doi":"https://doi.org/10.1517/13543784.12.4.655","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.12.4.655","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"doi:10.1517/eoid.12.4.655.23750","doi":"https://doi.org/10.1517/eoid.12.4.655.23750","is_oa":false,"landing_page_url":"https://doi.org/10.1517/eoid.12.4.655.23750","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:12665420","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12665420","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1820626129","https://openalex.org/W1929738822","https://openalex.org/W1944617386","https://openalex.org/W1965135842","https://openalex.org/W1971179661","https://openalex.org/W1974585730","https://openalex.org/W1976336543","https://openalex.org/W1977068888","https://openalex.org/W1980980884","https://openalex.org/W1981695853","https://openalex.org/W1984470001","https://openalex.org/W1984640322","https://openalex.org/W1992365076","https://openalex.org/W2002689986","https://openalex.org/W2004156074","https://openalex.org/W2010393027","https://openalex.org/W2019363012","https://openalex.org/W2021454992","https://openalex.org/W2023499731","https://openalex.org/W2029103055","https://openalex.org/W2030629377","https://openalex.org/W2033391356","https://openalex.org/W2039628468","https://openalex.org/W2046280658","https://openalex.org/W2052925983","https://openalex.org/W2055001194","https://openalex.org/W2070895158","https://openalex.org/W2089497091","https://openalex.org/W2090655622","https://openalex.org/W2091915431","https://openalex.org/W2092820864","https://openalex.org/W2095294033","https://openalex.org/W2109442247","https://openalex.org/W2135399947","https://openalex.org/W2151331628","https://openalex.org/W2155366295","https://openalex.org/W2161522345","https://openalex.org/W2162934794","https://openalex.org/W2166770851","https://openalex.org/W2167998777","https://openalex.org/W2256615984","https://openalex.org/W2321439674","https://openalex.org/W2417794537","https://openalex.org/W2431988721","https://openalex.org/W2469169783"],"related_works":["https://openalex.org/W2398290271","https://openalex.org/W2055595962","https://openalex.org/W2392794121","https://openalex.org/W2081229977","https://openalex.org/W2347723228","https://openalex.org/W2105453292","https://openalex.org/W2114801996","https://openalex.org/W1508292513","https://openalex.org/W3191110341","https://openalex.org/W2129957874"],"abstract_inverted_index":{"This":[0],"paper":[1],"reviews":[2],"the":[3,10,75,84],"clinical":[4],"pharmacology,":[5],"efficacy":[6,82],"and":[7,65,88,105,130],"safety":[8],"of":[9,53,77,86,91,101],"novel":[11],"antipsychotic":[12],"drug":[13],"aripiprazole.":[14],"All":[15],"published":[16,43],"citations":[17,28],"regarding":[18],"aripiprazole":[19,73,116],"were":[20,46],"reviewed":[21],"using":[22],"a":[23,50,56,98],"Medline((R))":[24],"search":[25],"(completed":[26],"for":[27],"through":[29],"mid-year,":[30],"2002).":[31],"In":[32,114],"addition,":[33,115],"abstracts":[34],"from":[35],"recent":[36],"scientific":[37],"meetings":[38],"presenting":[39],"data":[40],"not":[41,118],"yet":[42],"(nor":[44],"peer-reviewed)":[45],"reviewed.":[47],"Aripiprazole":[48],"has":[49,74],"unique":[51],"mechanism":[52],"action":[54],"as":[55,93,95],"dopamine":[57],"D2":[58],"partial":[59,63],"agonist,":[60],"serotonin":[61,66],"5-HT(1A)":[62],"agonist":[64],"5-HT(2A)":[67],"antagonist.":[68],"Like":[69],"other":[70],"new":[71],"antipsychotics,":[72],"profile":[76],"an":[78],"atypical":[79],"agent,":[80],"with":[81,120],"in":[83,127],"treatment":[85,132],"positive":[87],"negative":[89],"symptoms":[90],"psychosis":[92],"well":[94],"mood":[96],"symptoms,":[97],"low":[99],"rate":[100],"neurological":[102],"side":[103],"effects":[104],"no":[106],"significant":[107,121],"adverse":[108],"effect":[109],"on":[110],"serum":[111],"prolactin":[112],"concentrations.":[113],"was":[117],"associated":[119],"weight":[122],"gain":[123],"or":[124],"QTc":[125],"prolongation":[126],"both":[128],"acute":[129],"long-term":[131],"trials.":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2008122290","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
